Literature DB >> 16709515

Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.

K Huck1, H-J Laws, R Meisel, A Traeger, B Bernbeck, S Schonberger, V A Stackelberg, H Pape, D Dilloo.   

Abstract

Isolated renal relapse after allogeneic hematopoietic stem cell transplantation (alloHSCT) in children with acute lymphoblastic leukemia (ALL) is a rare condition. Generally, in ALL, the sites most frequently affected by extramedullary relapse are the central nervous system (CNS) and the testicles. Here we report on three young boys with relapsed B-precursor ALL, who underwent alloHSCT from HLA-identical siblings and suffered a histopathologically proven isolated unilateral renal relapse (two patients) or a combined renal and testicular relapse (one patient) 6, 10 and 12 months post alloHSCT. In all patients at the time of relapse bone marrow showed complete remission with complete donor hematopoiesis. They all received total body irradiation with partial shielding of the kidneys as part of their conditioning therapy, such that renal shielding could be an explanation for the observed accumulation of renal relapses. Moreover, during the past few years so called immune privilege has been postulated for frequent relapse sites such as the CNS, the testicles and the anterior chamber of the eye. Impaired accessability of these organs by cytotoxic T-cells (CTLs) with a reduced graft-versus-leukemia (GvL) effect after alloHSCT is based on a number of different molecular and cellular mechanisms. Similar mechanisms have been shown to be effective in the tubulointerstitial space of the kidney, rendering the kidney a potentially immune privileged site. Due to these observations we advocate sufficient treatment of the kidneys during conditioning therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709515

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

1.  Acute sciatica: an unusual presentation of extramedullary relapse of acute lymphoblastic leukemia.

Authors:  Hao-Chuan Liu; Giun-Yi Hung; Hsiu-Ju Yen; Ming-Yun Hsieh; Tzeon-Jye Chiou
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

2.  Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.

Authors:  Manman Deng; Jie Zha; Zhiwu Jiang; Xian Jia; Yuanfei Shi; Peng Li; Xiao Lei Chen; Zhihong Fang; Zhiqiang Du; Bing Xu
Journal:  J Transl Med       Date:  2018-02-28       Impact factor: 5.531

3.  Kidney and pancreatic extramedullary relapse in adult acute lymphoblastic leukemia: a case report and review of the literature.

Authors:  Leslie Skeith; Alejandro Lazo-Langner; Joy Mangel
Journal:  Case Rep Hematol       Date:  2013-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.